RxDoctor Payments Data

Lisa Charles Fields

Physician Assistant · North Chicago, ILNPI 1952313207

Payments from drug & device makers

$1,962in general payments, 2019–2025

Across 84 payments — averaging $23.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$326
  • Novo Nordisk$269
  • AstraZeneca$262
  • Boehringer Ingelheim$224
  • Lilly USA, LLC$166
  • AbbVie$144
  • plus $571 from 17 others

What the payments were for

  • Food & beverage$1,962100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,962 in reported general payments places this provider in the 80th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide78$99,929
JardianceEmpagliflozin54$73,216
OzempicSemaglutide58$65,879
RybelsusSemaglutide23$33,759
EliquisApixaban37$32,678
XifaxanRifaximin15$24,372
MounjaroTirzepatide22$23,317
LinzessLinaclotide38$19,867
JanuviaSitagliptin Phosphate12$19,333
FarxigaDapagliflozin Propanediol13$15,174
Bydureon BciseExenatide Microspheres13$13,245
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog38$11,792
SymbicortBudesonide/Formoterol Fumarate21$8,221
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$7,728
Tresiba Flextouch U-100Insulin Degludec15$6,598

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$166$123,246100 claims
Novo NordiskOzempic, Rybelsus$269$99,63881 claims
Boehringer IngelheimJardiance$224$73,21654 claims
AstraZenecaFarxiga, Symbicort$262$23,39534 claims
AbbVieLinzess$144$19,86738 claims
MerckJanuvia$108$19,33312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in North Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →